{"entity":{"type":"insider","cik":"0001261026","url":"/insider/0001261026","json_url":"/insider/0001261026.json","name":"FLAUM SANDER A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2004-05-27","last":"2018-03-07","span_basis":"filed_date"},"name_variants":[{"name":"FLAUM SANDER A","source":"filing","n_filings":4,"first_seen":"2004-05-27","last_seen":"2018-03-07"}],"transactions":[{"id":6518387,"accession":"0001209191-18-017705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-017705","line_url":"/filing/0001209191-18-017705#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001261026","owner_name":"FLAUM SANDER A","owner_display_name":"FLAUM SANDER A","owner_url":"/insider/0001261026","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2340.0,"shares_display":"2,340","price_per_share":53.94,"price_display":"53.94","price_state":"stated","total_value":126219.6,"total_display":"126,219.60","total_whole":"126,220","shares_owned_after":11374.0,"shares_owned_after_display":"11,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-07","scope":"insider"},{"id":3259705,"accession":"0001209191-16-152508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-152508","line_url":"/filing/0001209191-16-152508#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001261026","owner_name":"FLAUM SANDER A","owner_display_name":"FLAUM SANDER A","owner_url":"/insider/0001261026","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":78.66,"price_display":"78.66","price_state":"stated","total_value":393300.0,"total_display":"393,300.00","total_whole":"393,300","shares_owned_after":11374.0,"shares_owned_after_display":"11,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2016-11-30","scope":"insider"},{"id":8606257,"accession":"0001209191-15-086853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-086853","line_url":"/filing/0001209191-15-086853#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001261026","owner_name":"FLAUM SANDER A","owner_display_name":"FLAUM SANDER A","owner_url":"/insider/0001261026","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3225.0,"shares_display":"3,225","price_per_share":93.755,"price_display":"93.76","price_state":"stated","total_value":302359.875,"total_display":"302,359.88","total_whole":"302,360","shares_owned_after":16374.0,"shares_owned_after_display":"16,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2015-12-23","scope":"insider"},{"id":8606251,"accession":"0001209191-15-086853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-086853","line_url":"/filing/0001209191-15-086853#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001261026","owner_name":"FLAUM SANDER A","owner_display_name":"FLAUM SANDER A","owner_url":"/insider/0001261026","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9800.0,"shares_display":"9,800","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":411600.0,"total_display":"411,600.00","total_whole":"411,600","shares_owned_after":19599.0,"shares_owned_after_display":"19,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-12-23","scope":"insider"},{"id":580478,"accession":"0001209191-04-028285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-028285","line_url":"/filing/0001209191-04-028285#line-1","is_derivative":false,"issuer_cik":"0001123361","issuer_name":"VIASYS HEALTHCARE INC","issuer_ticker":"VAS","issuer_name_source":null,"issuer_url":"/issuer/0001123361","owner_cik":"0001261026","owner_name":"FLAUM SANDER A","owner_display_name":"FLAUM SANDER A","owner_url":"/insider/0001261026","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":21.27,"price_display":"21.27","price_state":"stated","total_value":10635.0,"total_display":"10,635.00","total_whole":"10,635","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-26","filed_date":"2004-05-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Director","n_filings":3,"first_seen":"2015-12-23","last_seen":"2018-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001123361","name":"VIASYS HEALTHCARE INC","url":"/issuer/0001123361","role":"Director","n_filings":1,"first_seen":"2004-05-27","last_seen":"2004-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001261026","retrieved_at":"2026-08-24T15:42:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}